Eversana Intouch, the AI-powered marketing agency arm of Eversana, pulled seasoned advertising exec Mike Guarino to serve as its new CEO. More: As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’ Source:
read morePresident Donald Trump has approved a plan to fire FDA Commissioner Marty Makary, M.D., according to a report from The Wall Street Journal. More: Trump plans to fire FDA chief Marty Makary: report Source: fierce
read moreDuring the weeklong stay by the Supreme Court to temporarily restore online access to the abortion pill mifepristone after a shock appeals court decision last Friday, scores of experts, industry heavyweights and former regulators have weighed in to defend the
read moreExplore how targeted protein degradation is reshaping drug discovery, enabling new approaches for difficult targets and advancing novel therapeutic modalities. More: Targeted Protein Degradation and Novel Modalities: Getting on the Frontline Source: fierce
read moreGilead raised its previous guidance of $800 million in revenues from the long-acting PrEP injectable Yeztugo based on a high-flying launch thus far. More: Gilead cranks up Yeztugo first-year sales forecast to B on 'unprecedented launch trajectory' Source: fierce
read moreWith an FDA decision date looming for its Duchenne muscular dystrophy (DMD) treatment deramiocel, Capricor Therapeutics has filed a lawsuit against its U.S. commercial partner, NS Pharma, and its parent company, Nippon Shinyaku. More: Capricor Therapeutics files breach-of-contract lawsuit against
read more© 1994 - 2026 B.M. Pharmaceuticals